Keyphrases
Prostate Cancer
100%
Cancer Immunotherapy
100%
Aberrant Expression
100%
Coenzyme A
100%
Immunotherapy Targets
100%
Racemase
100%
AMACR
100%
HLA-A24
50%
Derived Peptide
20%
Colorectal Cancer
20%
Peripheral Blood Mononuclear Cells
20%
Expression Level
10%
Amino Acid Sequence
10%
Cancer Patients
10%
Target Antigen
10%
Immunohistochemical Analysis
10%
High-level Expression
10%
Binding Affinity
10%
Cytotoxic T Lymphocytes
10%
Cytotoxic Activity
10%
Prostate Cancer Cell Lines
10%
PCR Analysis
10%
Binding Motif
10%
Prostate Cancer Cells
10%
Normal Prostate
10%
Cancer-specific
10%
Peptide Vaccine
10%
Prostate Cancer Patients
10%
Prostate Tissue
10%
Kidney Cancer
10%
Fatty Acid Derivatives
10%
Cytotoxic T Lymphocyte Epitope
10%
β-oxidation
10%
Branched-chain Fatty Acids
10%
Vaccine Candidate
10%
Benign Prostate Disease
10%
Immunology and Microbiology
Cancer Immunotherapy
100%
HLA A24 Antigen
100%
Coenzyme
100%
Cytotoxic T Cell
40%
Peripheral Blood Mononuclear Cell
40%
Immunotherapy
20%
Cancer Cell
20%
Cytotoxicity
20%
Prostate Cancer Cell Line
20%
Epitope
20%
Amino Acid Sequence
20%
Peptide Vaccine
20%
Binding Affinity
20%
Reverse Transcription Polymerase Chain Reaction
20%
Fatty Acid Oxidation
20%
Prostate Tissue
20%
Medicine and Dentistry
Prostate Cancer
100%
Cancer Immunotherapy
100%
Alpha-Methylacyl-CoA Racemase
100%
HLA A24 Antigen
45%
Malignant Neoplasm
36%
Peripheral Blood Mononuclear Cell
18%
Cytotoxic T-Cell
18%
Cancer Cell
9%
Peptide Sequence
9%
Binding Affinity
9%
Fatty Acid Oxidation
9%
Fatty Acid
9%
Cytotoxicity
9%
Immunotherapy
9%
Prostate Cancer Cell Line
9%
Reverse Transcription Polymerase Chain Reaction
9%
Colorectal Carcinoma
9%
Epitope
9%
Kidney Cancer
9%
Peptide Vaccine
9%
Prostate Tissue
9%
Fatty Acid Derivative
9%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Prostate Cancer
100%
Immunotherapy
100%
2 Methylacyl Coenzyme A Racemase
100%
HLA A24 Antigen
45%
Amino Acid
9%
Fatty Acid
9%
Epitope
9%
Colorectal Carcinoma
9%
Kidney Cancer
9%
Peptide Vaccine
9%
Fatty Acid Derivative
9%
Cytotoxicity
9%
Biochemistry, Genetics and Molecular Biology
Cancer Immunotherapy
100%
Alpha-Methylacyl-CoA Racemase
100%
Cancer Cell
18%
Peripheral Blood Mononuclear Cell
18%
Cytotoxic T Cell
18%
Enzyme
9%
Beta Oxidation
9%
Binding Affinity
9%
Reverse Transcription Polymerase Chain Reaction
9%
Cytotoxicity
9%
Peptide Sequence
9%
Vaccine Peptide
9%